Serum Institute of India (SII) has informed the government that it will be able to supply around 22 crore doses of Kovidshield next month as the Center exports surplus COVID-19 vaccines in the coming fourth quarter under ‘Vaccine Maitri’. announced the resumption. ‘ program.
In a communication to the Center on Monday, Prakash Kumar Singh, director of government and regulatory affairs at SII, said that the company has increased the production capacity of Kovishield and it will be able to supply 21.90 crore doses to Indian government and private hospitals in October. will be able
The Pune-headquartered vaccine maker has increased the manufacturing capacity of Covishield to over 200 million doses per month.
“Since January 2021, we have supplied 66.33 crore doses of Covisheeld to MoHFW, Government of India besides supplying over 7.77 crore doses to state governments and private hospitals till the evening of 19 September 2021,” the pharmaceutical company said.
“All this has been made possible under the dynamic leadership and compassionate direction of our Prime Minister Narendra Modi ji, the continuous support of the Ministry of Health and Government of India, the visionary leadership of our CEO Dr Adar C Poonawalla as well as the tireless efforts of Team SIIPL. with,” news agency PTI Quoting a source.
Singh further assured that by the end of December, the company will fulfill the recent supply order of 66 crore COVID-19 vaccine doses keeping in mind the timeline.
“At this juncture, I can assure you that by December 31, 2021, we will have completed the supply of 66 crore doses of Kovishield against the recent order and will touch the supply of over 130 crore doses of Covishield in the year 2021 We are working tirelessly to fulfill our Prime Minister’s dream of successfully completing the world’s largest vaccination campaign so that our country can overcome the COVID-19 pandemic,” the communication said.
India will resume export of surplus covid vaccines
Earlier on Monday, Union Health Minister Mansukh Mandaviya said that the country will resume exporting additional COVID-19 vaccines in the fourth quarter of 2021 under the ‘Vaccine Friendship’ program and to meet its commitment to the COVAX global pool. , but will do his own vaccination. Citizens remain the top priority of the government.
Talking about the expected production and supply trends in the coming months, the Minister said that the Center received over 30 crore doses of COVID-19 vaccines in October and over 100 crore doses in the quarter from October-December. Will be
The cumulative doses administered so far under the COVID-19 vaccination campaign across the country have crossed 82 crores.
Of all the vaccines administered, about 88.45% are Covishield, about 11.44% are Bharat Biotech’s Covaccine and less than 1% are Sputnik V.
India administered a record number of over 2.50 crore COVID-19 vaccine doses on the occasion of Prime Minister Narendra Modi’s 71st birthday on September 17.
The daily COVID-19 vaccination in the country was over 1 crore on 6 September, 31 August and 27 August.
According to the ministry, it took 85 days for India to touch the 10 crore vaccination figure, 45 days to cross the 200 million mark and 29 more days to reach the 30 crore mark.
It said that it took 24 days for the country to reach 40 crore from 300 million doses and then 20 days to cross the 50 crore vaccination mark on 6 August.
It took 19 more days to cross the 60 crore mark and only 13 days to reach 70 crore from 60 crore on 7th September.
Then it took only 11 days to reach from 70 crores to 80 crores.
As per reports, more than 22% of the adult population of the country has received both doses of the coronavirus vaccine and around 65% have received at least one dose.
with agency input
Don’t miss a story! Stay connected and informed with Mint.
download
Our App Now!!
.